A senior ICMR official told a parliamentary panel on Wednesday that the phase two clinical trial of two locally evolved COVID-19 vaccine applicants is approaching the final touch and that emergency approval of a vaccine can be considered as if the Center decided, according to an ITP. Report.
The Director-General of the Medical Research Council of India (ICMR), Balram Bhargava, has informed the members of the Standing Parliamentary Committee on Internal Affairs that candidate vaccines evolved through Bharat Biotech, Cadila and the Serum Institute of India are in other stages of testing. said an MP provide at the meeting, PTI reported.
Responding when India has a COVID-19 vaccine, the parliamentarian quoted Bhargava as saying that the final trial takes six to nine months, but if the government decides, it can be considered an emergency authorization, according to the PTI news agency.
CoVID-19 vaccine applicants coordinated through Bharat Biotech and Zydus Cadila are approaching the final touch of Phase II trials, the official said. Meanwhile, the Serum Institute of India is able to initiate the Phase II trial of the COVID-19 vaccine developed through the University of Oxford and AstraZeneca. The Swedish British company has partnered with SII to manufacture the Oxford COVID-19 vaccine for India and other low- and middle-income countries.
“I need to tell other people that the skill of our scientists is like that of ‘rishi equipped’ and that they work very hard in laboratories. Three vaccines are in other stages of testing. When scientists give us the green signal, it will be produced on a giant scale and all the arrangements have been made for it,” Prime Minister Narendra Modi said as he was heading to the country on Independence Day.
The Pune-based drug manufacturer decided to test at 17 sites in India. A total of 1,600 applicants will participate in the study. Each player will get two doses within 4 weeks. The first dose will be given on day one and the moment dose will be scheduled for day 29, depending on the study design.
Russia has become the first country in the world to sign a COVID-19 vaccine. Russian President Vlamdimir Putin said the vaccine “had passed all the mandatory tests.” Nicknamed Sputnik V, the vaccine evolved through the Gamaleya Research Institute and the Russian Ministry of Defense. The vaccine is expected to provide coronavirus immunity for up to two years, according to the Russian Ministry of Health. Clinical human studies began on June 17 in 76 volunteers. Russia signed the vaccine after less than two months of human testing.
Click here to read Mint ePaperLivemint.com is now on Telegram. Join the Livemint channel on your telegram and updated
Log in to our to save your favorites. It’ll only take a moment.
Your query has expired, reconnect.
You are now subscribed to our newsletters. If you can’t find any email from us, check your spam folder.